BSP Pharmaceuticals

BSP Pharmaceuticals S.p.A., founded in 2006, is a prominent Contract Development and Manufacturing Organization (CDMO) based in Italy, specializing in end-to-end pharmaceutical services. The company focuses on oncological and non-cytotoxic innovative drugs, offering comprehensive support across the entire product lifecycle. With a global client base and operations spanning 2 locations, BSP Pharmaceuticals provides development, clinical, and commercial supply services for sterile injectable and oral dosage forms, as well as for complex Antibody-Drug Conjugates (ADCs). Their expertise encompasses formulation, process development, and navigating regulatory affairs, ensuring clients receive integrated solutions from concept to market. The company is committed to high standards of quality and sustainability in its operations.

The organization operates state-of-the-art, high containment facilities specifically designed for the safe handling of potent compounds, underscoring its dedication to specialized pharmaceutical manufacturing. This advanced infrastructure supports the development and production of challenging therapeutic agents. BSP Pharmaceuticals prides itself on its skilled workforce and collaborative approach, enabling them to manage intricate projects efficiently. To gain insight into the professionals driving these advancements, you can Meet BSP Pharmaceuticals' team and discover their collective expertise in pharmaceutical development and manufacturing.

With a revenue of $51.7M and an employee range of 1,000-5,000, BSP Pharmaceuticals demonstrates significant scale within the competitive CDMO landscape. They serve a diverse international clientele, positioning themselves as a key partner for pharmaceutical companies seeking specialized manufacturing capabilities. Their strategic focus on innovative drugs and potent compounds, combined with robust operational capacity, solidifies their role in advancing global healthcare solutions. The company's presence in theView more...